Mobile IV therapy in Maine: the new Chapter 15 rules, explained

Source-forward, as regulatory topics should be: this guide works from the adopted rule text — the Chapter 15 Joint Rule (PDF, maine.gov) — with professional-association and health-law commentary for context. It is not legal advice; the official text and your attorney govern.

Where this came from

Maine's three licensing boards — Medicine, Osteopathic Medicine, and Nursing — watched the same thing everyone in this industry watched: IV therapy and med spa services growing fast, with wildly uneven clinical practices underneath. Their answer was a joint rule, effective July 2026, so that the same text binds physicians, PAs, APRNs, and nurses alike. The rule's own opening frames the point: these are medical procedures, and they get a minimum standard of practice. The American Med Spa Association's summary is a useful orientation (AmSpa: New IV Rules in Maine), but the rule text itself is short enough to read — and worth reading.

What's settled

1. A Maine license, and a real prescriber relationship, per patient

Physicians, PAs, and APRNs who examine, diagnose, or authorize IV preparations for a patient located in Maine must hold an active Maine license (or other legal authorization to practice in Maine); LPNs and RNs need an active Maine license or a multistate compact license.

And the provision with the widest reach: being the owner, investor, or designated medical director of an IV business is explicitly insufficient to create the licensee-patient relationship required before prescribing or administering IV therapy. The name-on-the-wall medical director model — where the director authors protocols but never meets patients — does not satisfy Maine's rule. Every patient must actually be somebody's patient: the relationship begins when the person seeks care, the licensee agrees to examine or treat, and the person agrees to receive care.

2. A real exam — and the end of the questionnaire GFE

The default is an in-person clinical interview and physical examination by the physician, PA, or APRN. Telehealth is permitted only when the technology is sufficient to establish an informed diagnosis as though the exam had been performed in person — and the rule's own example is pointed: for IV fluids, listening to heart and lungs and checking for edema matters, because fluid overload is a contraindication for additional fluids. The boards chose an example that says, in effect: a bare video call may not be enough for IVs.

Just as pointed: a static internet questionnaire is explicitly not a clinical interview. The rule distinguishes a static set of questions with static answers from an adaptive, interactive interview — and only the latter can support treatment or prescriptions. The asynchronous form-review model — patient fills out a form, a prescriber somewhere clicks approve — is non-compliant by name in Maine.

What survives: in-person exams, and facilitated telehealth — an on-scene nurse or trained staff member providing hands, instruments, and vitals while the prescriber examines remotely. Build the workflow so the prescriber can actually assess what the standard of care requires for fluids. (For the national picture on exams, see our Good Faith Exam requirements guide.)

3. Orders, not menus

Administration of IV preparations — the rule is explicit that this includes plain saline with additives — must result from a valid physician, PA, or APRN order in the usual course of professional practice, not from a patient-driven menu.

The distinction that matters operationally: a patient can still request a Myers cocktail — expressing a preference is not the violation. The violation is administration flowing from that selection without independent prescriber judgment. Request → assessment → order → administration. The menu proposes; the prescriber disposes.

4. The end of field mixing

Chapter 15 addresses compounding — which it treats as including mixing saline with one or more additives — head-on:

• USP <797> sterile compounding standards apply to IV preparations, everywhere they're prepared, by everyone who prepares them — the rule lists nurses, physicians, and treatment sites of every kind by name.
• The "immediate use" exception that many IV businesses have leaned on to justify field mixing is called out as a misreading of federal law: walk-in, mobile, and concierge IV services do not fall under it.
• In a clinic or office setting, when compounding happens on-site, a licensed physician must perform it — and for valid clinical reasons under federal and state law, not in response to a menu selection.

Put together: mobile operators can't mix on scene, and clinics can only mix if a physician personally does the mixing — which almost no IV lounge staffs for. For most operators, both lanes converge on the same answer: source ready-to-administer bags from a licensed sterile compounding facility. (On what USP <797> conditions involve, see our hood guide; on supplier strategy, our supply chain guide.)

5. No standing orders as a substitute for judgment

The keystone provision is one sentence long: using standing orders in these businesses for individualized assessment, diagnosis, and treatment of patients is unprofessional conduct that may result in disciplinary action.

This is the sentence that retires the dominant national model — a medical director writes protocols, the field executes them, and the director never knows the patients exist. In Maine, protocol-as-medicine is over. Every treatment decision belongs to a prescriber who actually assessed that patient.

6. Records to a traditional-practice standard

The rule enumerates (Section 3, subsection 10) what the chart must contain: patient history including current medical issues and medications, physical examination results, nursing assessment, diagnosis, laboratory and diagnostic results where applicable, the nature and purpose of recommended interventions, the burden, risks, and expected benefits of all options including foregoing treatment, records of drugs and IV fluids prescribed, dispensed, and administered, the patient's decision, and the need for follow-up or emergency care.

And the rule states the principle behind the list plainly: licensees in an IV therapy business are held to the same standards of care and professional ethics as in traditional healthcare environments. The house-call setting changes nothing about the chart.

What's genuinely unclear

Honest operators and their attorneys will want answers on at least three points where the text leaves room:

• Emergency standing orders. The standing-order ban targets protocols used for individualized assessment and treatment. Anaphylaxis and adverse-reaction protocols — the emergency kit every IV operation legitimately carries — are crisis response, not treatment planning, and reading the ban to cover them would be a surprising over-correction. But the rule doesn't carve them out in so many words. This is a question for counsel, not a guess.
• What telehealth setup suffices for fluids. The rule permits telehealth "sufficient to establish an informed diagnosis" and then gives a fluid-overload example that implies auscultation matters. Whether a facilitated exam with connected instruments clears the bar for every patient — or whether some presentations require in-person — is a standard-of-care judgment the rule frames but doesn't resolve.
• Where "request" ends and "menu" begins. Booking flows, published service lists, and marketing all still exist. The rule targets administration driven by selection; how the boards will view specific booking-and-marketing patterns is untested. The conservative structure: every published offering is a starting point for assessment, and your records show prescriber judgment on every order.

What a compliant Maine operation looks like now

1. A Maine-licensed prescriber genuinely in the loop — employed, contracted, or telehealth-facilitated — establishing a real relationship with each patient.
2. A GFE workflow built for the exam requirement: in-person where feasible; facilitated telehealth with on-scene vitals and assessment tools where not. No questionnaire-only approvals, anywhere in the flow.
3. Individualized orders on every visit. The booking is the request; the order is the medicine.
4. Compliant sourcing for your bags — two lanes, and only one of them travels. For most operators, that means pharmacy-sourced, ready-to-hang bags from a licensed sterile compounding facility — build those supplier relationships now, because the qualified pool is small and the whole state's demand is about to route through it (expect real lead times, beyond-use dates, and unit costs above DIY mixing; price accordingly). The alternative exists but is narrow: in-clinic compounding is permitted when a licensed physician personally performs it — not supervises, performs — for valid clinical reasons, in conditions meeting USP <797> sterile compounding standards (see our hood guide for what that entails). Note what's not on this list: an NP or nurse mixing under physician oversight isn't a lane Chapter 15 offers, and the field isn't a compounding site at all — mobile and concierge services get no immediate-use exception, so bags going out the door go out finished.
5. Charts that would stand up in any practice — the rule's medical-records list (Section 3, subsection 10) is your checklist.

What to ask an attorney

• How should our emergency and adverse-reaction protocols be documented so they don't read as prohibited standing orders?
• Does our telehealth GFE setup meet the exam standard for IV fluids specifically — and for which patient populations?
• Are our booking flow and service marketing structured as requests-for-assessment rather than menu-driven medicine?
• Who, exactly, is authorized to compound for our operation under this rule and federal law — and if we plan any in-clinic compounding, does our setup meet the physician-performed and USP <797> requirements?
• Which compounding suppliers are properly licensed to ship into Maine, and what do our sourcing records need to show?
• Do our prescriber agreements establish the licensee-patient relationship the rule requires — beyond a medical-director title?

Chapter 15 doesn't ban anything serious operators weren't already doing — it bans the shortcuts. Real exams, real orders, real records, professionally compounded bags. For the operators who've been running it right, Maine just turned discipline into a moat. And with three boards signing one rule, expect other states to borrow this language — the operators who adapt now are rehearsing for everywhere.